A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis
Clinical trial NCT05784246 · COMPLETED
Trial details
- NCT number
- NCT05784246
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-22
- Primary completion
- 2026-05-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.